highly significantp < 0.01
Combination of fisetin and sorafenib treatment produced highly significant tumor growth inhibition (66.43%; p < 0.01) with tumor volume of 420.37 mm 3 only as compared to the control group.
Combination of fisetin and sorafenib treatment produced highly significant tumor growth inhibition (66.43%; p < 0.01) with tumor volume of 420.37 mm 3 only as compared to the control group.